Solid Neoplasm — Trials

Solid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1,151–1,200 of 1,302 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04762641	This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors	recruiting	Phase 1	100	ABL Bio, Inc.INDUSTRY	2	Feb 6, 2025	clinicaltrials
NCT05662397	A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody	active not recruiting	Phase 1 / Phase 2	77	HotSpot Therapeutics, IncINDUSTRY	3	Feb 4, 2025